These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
472 related articles for article (PubMed ID: 750276)
1. Effect of vitamin A acetate on urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats. Miyata Y; Tsuda H; Matayoshi-Miyasato K; Fukushima S; Murasaki G; Ogiso T; Ito N Gan; 1978 Dec; 69(6):845-8. PubMed ID: 750276 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of 13-cis-retinoic acid on urinary bladder carcinogenesis induced in C57BL/6 mice by N-butyl-N-(4-hydroxybutyl)-nitrosamine. Becci PJ; Thompson HJ; Grubbs CJ; Squire RA; Brown CC; Sporn MB; Moon RC Cancer Res; 1978 Dec; 38(12):4463-6. PubMed ID: 719631 [TBL] [Abstract][Full Text] [Related]
3. 13-cis-Retinoic acid: inhibition of bladder carcinogenesis induced in rats by N-butyl-N-(4-hydroxybutyl)nitrosamine. Grubbs CJ; Moon RC; Squire RA; Farrow GM; Stinson SF; Goodman DG; Brown CC; Sporn MB Science; 1977 Nov; 198(4318):743-4. PubMed ID: 910158 [TBL] [Abstract][Full Text] [Related]
4. Summation effect of N-butyl-n-(4-hydroxybutyl)nitrosamine, N-(4-(5-nitro-2-furyl)-2-thiazoly)formamide, N-2-fluoroenylacetamide, and 3,3'-dichlorobenzidine on urinary bladder carcinogenesis in rats. Tatematsu M; Miyata Y; Mizutani M; Hananouchi M; Hirose M Gan; 1977 Apr; 68(2):193-202. PubMed ID: 892293 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of an aromatic retinoic acid analog on urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Murasaki G; Miyata Y; Babaya K; Arai M; Fukushima S; Ito N Gan; 1980 Jun; 71(3):333-40. PubMed ID: 7418979 [TBL] [Abstract][Full Text] [Related]
6. Trisodium nitriloacetate monohydrate: promoting effect in urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Hiasa Y; Kitahori Y; Konishi N; Shimoyama T; Miyashiro A J Natl Cancer Inst; 1985 Jan; 74(1):235-9. PubMed ID: 3855482 [TBL] [Abstract][Full Text] [Related]
7. Synergistic effect of urinary bladder carcinogenesis in rats treated with N-butyl-n-(4-hydroxybutyl)nitrosamine, N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide,N-2-fluorenylacetamide, and 3,3'-dichlorobenzidine. Tsuda H; Miyata Y; Murasaki G; Kinoshita H; Fukushima S Gan; 1977 Apr; 68(2):183-92. PubMed ID: 892292 [No Abstract] [Full Text] [Related]
8. Effect of phenacetin and caffeine on the urinary bladder of rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Nakanishi K; Fukushima S; Shibata M; Shirai T; Ogiso T; Ito N Gan; 1978 Jun; 69(3):395-400. PubMed ID: 669140 [TBL] [Abstract][Full Text] [Related]
9. Chemoprevention by indomethacin of N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder tumors. Grubbs CJ; Juliana MM; Eto I; Casebolt T; Whitaker LM; Canfield GJ; Manczak M; Steele VE; Kelloff GJ Anticancer Res; 1993; 13(1):33-6. PubMed ID: 8476227 [TBL] [Abstract][Full Text] [Related]
10. Strong promoting activity of reversible uracil-induced urolithiasis on urinary bladder carcinogenesis in rats initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Shirai T; Tagawa Y; Fukushima S; Imaida K; Ito N Cancer Res; 1987 Dec; 47(24 Pt 1):6726-30. PubMed ID: 3677102 [TBL] [Abstract][Full Text] [Related]
11. Dose-dependent promoting effect of trisodium nitrilotriacetate monohydrate on urinary bladder carcinogenesis in Wistar rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Kitahori Y; Konishi N; Shimoyama T; Hiasa Y Jpn J Cancer Res; 1985 Sep; 76(9):818-22. PubMed ID: 3932279 [TBL] [Abstract][Full Text] [Related]
12. Effect of delay in administration of 13-cis-retinoic acid on the inhibition of urinary bladder carcinogenesis in the rat. Becci PJ; Thompson HJ; Grubbs CJ; Brown CC; Moon RC Cancer Res; 1979 Aug; 39(8):3141-4. PubMed ID: 455298 [TBL] [Abstract][Full Text] [Related]
13. Dose response of saccharin in induction of urinary bladder hyperplasias in Fischer 344 rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Nakanishi K; Hagiwara A; Shibata M; Imaida K; Tatematsu M; Ito N J Natl Cancer Inst; 1980 Nov; 65(5):1005-10. PubMed ID: 6933236 [TBL] [Abstract][Full Text] [Related]
14. Enhancing effect of diethylstilbestrol on urinary bladder carcinogenesis in neonatally castrated male rats. Ogiso T; Arai Y; Fukushima S; Nishizuka Y; Ito N Gan; 1982 Dec; 73(6):862-9. PubMed ID: 7160579 [TBL] [Abstract][Full Text] [Related]
15. Urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in dogs. Okajima E; Hiramatsu T; Hirao K; Ijuin M; Hirao Y; Babaya K; Ikuma S; Ohara S; Shiomi T; Hijioka T; Ohishi H Cancer Res; 1981 May; 41(5):1958-66. PubMed ID: 7214364 [TBL] [Abstract][Full Text] [Related]
16. Effect of simultaneous administration of leupeptin on induction of bladder tumors in rats by N-butyl-N-(4-hydroxybutyl)-nitrosamine. Kakizoe T; Matsukura N; Aoyagi M; Kawachi T; Sugimura T Gan; 1980 Feb; 71(1):138-40. PubMed ID: 7380132 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of N-n-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder cancer in rats by administration of disulfiram in the diet. Irving CC; Tice AJ; Murphy WM Cancer Res; 1979 Aug; 39(8):3040-3. PubMed ID: 455288 [TBL] [Abstract][Full Text] [Related]
18. Patterns of epithelial proliferation revealed by continuous administration of bromodeoxyuridine during urinary bladder carcinogenesis in rats. Tatematsu M; Fukushima S; Aoki T; Mera Y; Inoue T; Ito N Jpn J Cancer Res; 1987 Sep; 78(9):879-82. PubMed ID: 3117745 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of urinary bladder cancer by N-(ethyl)-all-trans-retinamide and N-(2-hydroxyethyl)-all-trans-retinamide in rats and mice. Thompson HJ; Becci PJ; Grubbs CJ; Shealy YF; Stanek EJ; Brown CC; Sporn MB; Moon RC Cancer Res; 1981 Mar; 41(3):933-6. PubMed ID: 7459880 [TBL] [Abstract][Full Text] [Related]
20. Different susceptibilities of the urinary bladder epithelium of animal species to three nitroso compounds. Hirose M; Fukushima S; Hananouchi M; Shirai T; Ogiso T Gan; 1976 Apr; 67(2):175-89. PubMed ID: 964550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]